Release
2021/02/22
OSAKA, Japan, February, 22, 2021 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D. hereafter "Shionogi") today announced that Shionogi has agreed with Osaka and Tokyo prefecture to dispatch employees to the health centers in areas where COVID-19 have spread in each prefecture to support COVID-19 epidemic prevention activities.
With the spread of COVID-19 infection from November 2020, the burden on the medical system and health centers has increased in order to deal with the rapidly increasing number of infected people, and the situation has continued to be tight. Currently, with the improvement of indicators such as the number of newly infected people and the bed usage rate, we are gradually regaining calm, but maintaining and strengthening the system to protect the safety and security of society is an urgent issue. In view of this situation, Shionogi has made an offer to Osaka and Tokyo prefecture to dispatch employees to a health center where work is tight due to the spread of COVID-19 infection, to contribute to the prevention of the spread of COVID-19.
Outline of employee dispatch based on this agreement
[Dispatch period]
February 22nd to March 31st, 2021 *
* If an "emergency declaration" or "priority measures such as prevention of spread" are declared with the next spread of the COVID-19 infection, and the burden on the health center is increasing, the next dispatch period should be considered to be set.
[Dispatch employees]
About 20-30 employees, depending on the tightness of work in health centers of each prefecture.
[Implementation work]
Administrative assistance for public health nurses (mainly public health nurse peripheral work)
・ Data entry of patient outbreak information,
・ Preparation and sending of documents such as work restriction notifications and inspection requests
・ Logistics support for epidemiological investigations such as telephone interviews
Shionogi is committed to “Protecting people worldwide from the threat of infectious diseases” as our key focus. In addition to our continued efforts for the research and development of therapeutics, we are also pursuing total care for infectious diseases, through awareness building, prevention, diagnosis, and treatment of exacerbations, as well as addressing the infection itself. Furthermore, by supporting the activities of organizations with the same purpose, we will contribute to the reconstruction of social safety and security and fulfill our social responsibilities.